UPDATE: Amgen and FDA Agree to Modify Nplate Risk Evaluation and Mitigation Strategy


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Amgen (NASDAQ: AMGN) todayannounced the U.S. Food and Drug Administration has modified therequirements of the Nplate Risk Evaluation and MitigationStrategy Program. Prescribing physicians, patients and institutions areno longer required to enroll in the safety monitoring program, called theNplate NEXUS Program, in order to prescribe or receive Nplate.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsFDA